What to Expect from the Report
The 2022 ESMO Annual Meeting is over, but the connections, data, and information shared at the conference will stay with us. Our team of analysts have carefully screened all the ESMO 2022 abstracts and identified 24 (18 clinical, 5 preclinical) abstracts relating to adoptive cell drugs and trials, and added them to the Beacon Adoptive Cell database.
This report encompasses a detailed analysis of the 24 abstracts in the adoptive cell space, including; clinical abstracts by phase, trial outline summaries and preclinical and clinical abstract summaries.
You will also find a full summary of all 24 adoptive cell abstracts ordered by; therapeutic class, target distribution and disease distribution. The abstract summaries include the following data; the name and link to the drug (on Beacon), trial sponsor/developer, abstract/ trial ID, phase, disease indication and description/dosing.